Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CES2 | O00748 | 2/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5933104 | 1.00 | MEN1 (0.54) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL7653445 | 0.98 | MEN1 (0.57) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL7633832 | 0.98 | MEN1 (0.57) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL9361430 | 0.98 | MEN1 (0.57) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL5932976 | 0.98 | MEN1 (0.57) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL5932437 | 0.98 | MEN1 (0.57) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL1032757 | 0.93 | TSHR (0.50) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL11145409 | 0.93 | TSHR (0.50) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL5483768 | 0.93 | TSHR (0.50) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL5487135 | 0.93 | TSHR (0.50) | MEN1THRBHTTKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0585239-B1 | VISIBLY TRANSPARENT UV SUNBLOCK AGENTS AND METHODS OF MAKING SAME | SUN SMART INC (US) | 1998-09-23 | — | — | EP | claimed |
| JP-7168141-A | — | — | None | — | — | JP | disclosed |
| JP-56036601-A | — | — | None | — | — | JP | disclosed |
| US-20090076322-A1 | CAPSULE ENDOSCOPE | FUJIFILM CORPORATION (JP) | 2009-03-19 | — | — | US | disclosed |
| US-20090061233-A1 | Method of manufacturing flexible substrate for electronic device, method of manufacturing electronic device and electronic device manufactured thereby | FUJIFILM CORPORATION | 2009-03-05 | — | — | US | disclosed |
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | MITSUI CHEMICALS, INC. (JP) | 2006-04-27 | — | — | US | disclosed |
| US-20050044778-A1 | Fuel compositions employing catalyst combustion structure | OCTANE INTERNATIONAL, LTD. | 2005-03-03 | — | — | US | disclosed |
| EP-1484191-A1 | REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE | Sony Corporation (JP) | 2004-12-08 | — | — | EP | disclosed |
| JP-H07168141-A | METHOD FOR DYEING PLASTIC LENS | NIKON CORP | 1995-07-04 | — | — | JP | disclosed |
| US-5336535-A | Plastic liquid crystal display device | SHARP KABUSHIKI KAISHA (JP) | 1994-08-09 | — | — | US | disclosed |
| EP-0081344-B1 | RESIN BINDER FOR FIBRE COMPOSITE MATERIALS | FORD MOTOR COMPANY LIMITED (GB) | 1987-07-22 | — | — | EP | disclosed |
| US-4448941-A | EPOXY-AMINO ALCOHOL-A GLYCIDYL ACRYLATE ADDUCT CROSSLINKED BY AN USATURATED DILUENT | FORD MOTOR COMPANY (US) | 1984-05-15 | — | — | US | disclosed |
| EP-0081344-A1 | Resin binder for fibre composite materials | FORD MOTOR COMPANY LIMITED (GB) | 1983-06-15 | — | — | EP | disclosed |
| JP-S5636601-A | RESIN COMPOSITION FOR HIGH REFRACTIVE INDEX PLASTIC LENS | SEIKO EPSON CORP | 1981-04-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060088786-A1 | Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus | ALPG, TRPC6, GNRHR | MEN1 1357/4885THRB 3407/4885HTT 2694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.